Name | D-Fructose-1,6-Diphosphate |
Synonyms | CPC 111 F1,6diP Fosfructose fructose diphosphate fructose-1,6-biphosphate fructose-1,6-bisphosphate Hexose diphosphate hydrate D-Fructose-1,6-Diphosphate D-Fructose 1,6-bisphosphate D-fructose 1,6-bisphosphate 1,6-di-O-phosphono-D-fructose Fructose 1,6-diphosphate sodium D-Fructose 1,6-bisphosphoric acid 1,6-di-O-phosphonohex-2-ulofuranose 1,6-di-O-phosphono-D-fructofuranose beta-D-fructofuranose-1,6-diphosphate 1,6-di-O-phosphono-beta-D-fructofuranose 2,5-anhydro-1,6-di-O-phosphono-D-glucitol d-[3-13C]fructose 1,6-bisphosphate(sodiuM salt) |
CAS | 488-69-7 |
EINECS | 207-683-6 |
InChI | InChI=1/C6H14O11P2/c7-5-3(1-15-18(9,10)11)17-4(6(5)8)2-16-19(12,13)14/h3-8H,1-2H2,(H2,9,10,11)(H2,12,13,14)/t3-,4+,5-,6-/m1/s1 |
Molecular Formula | C6H14O12P2 |
Molar Mass | 340.12 |
Density | 2.007±0.06 g/cm3(Predicted) |
Melting Point | 72--74°C |
Boling Point | 819.8±75.0 °C(Predicted) |
Flash Point | 380.3°C |
Solubility | Methanol (Slightly), Water (Slightly) |
Vapor Presure | 5.52E-23mmHg at 25°C |
Appearance | Solid |
Color | White to Off-White |
pKa | 1?+-.0.10(Predicted) |
Storage Condition | Hygroscopic, -20°C Freezer, Under inert atmosphere |
Stability | Hygroscopic |
Sensitive | Easily absorbing moisture |
Refractive Index | 1.585 |
Use | Cardiovascular system drugs |
UN IDs | 1759 |
Hazard Class | 8 |
Packing Group | III |
Reference Show more | 1. Xiaonan Wang, Ying Liu, Juan Zhang, Genxi Li, Oxime chemistry-mediated covalent capturing on electrode surface with guanidinium recognition and application for aldolase activity assay, Sensors and Actuators B: Chemical, Volume 242, 2017, Pages 687-693, ISS |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
efficacy and action | fructose diphosphate sodium (1,6 fructose diphosphate, FDP), as an important intermediate product of intracellular glucose metabolism, has the function of regulating several enzyme activities in glucose metabolism, and is a molecular level drug to restore and improve cell metabolism. it is clinically used to treat coronary heart disease, angina pectoris, myocardial infarction, cerebral infarction and shock to achieve satisfactory results. In recent years, the clinical application of this drug in the treatment of other diseases has made new progress, and its application is becoming more and more extensive. |
biological activity | Fosfructose (Diphosphofructose) is a cell-protective natural sugar phosphate with potential for cardiovascular ischemia, sickle cell anemia and asthma research. Fosfructose works by stimulating anaerobic glycolysis, which produces adenosine triphosphate under ischemic conditions. |
use | cardiovascular system medication. |